Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Source
Journal of hematology and oncology - ISSN 1756-8722-17:1 (2024) p. 1-19
Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells
Source
Methods in cell biology-p. 143-160
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed
Source
- () p.
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study
Source
Vaccine - ISSN 0264-410X-41:10 (2023) p. 1657-1667